Alembic Pharmaceuticals Limited (APLLTD) — Capital Reinvestment Ratio
Alembic Pharmaceuticals Limited (APLLTD) has a Capital Reinvestment Ratio of 0.71x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs4.03 Billion) in capital expenditures (Rs2.88 Billion). See APLLTD equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Alembic Pharmaceuticals Limited Capital Reinvestment Ratio (2011–2025)
This chart tracks Alembic Pharmaceuticals Limited's Capital Reinvestment Ratio across 15 annual periods. Check total reinvestment intensity of Alembic Pharmaceuticals Limited to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Alembic Pharmaceuticals Limited (2011–2025)
Year-by-year Capital Reinvestment Ratio for Alembic Pharmaceuticals Limited from 2011 to 2025. For live market cap and broader valuation context, see APLLTD stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 6.41x | Rs879.70 Million | Rs5.64 Billion | ▲ +1471.5% |
| 2024 | 0.41x | Rs8.03 Billion | Rs3.27 Billion | ▼ -33.4% |
| 2023 | 0.61x | Rs7.24 Billion | Rs4.43 Billion | ▼ -20.5% |
| 2022 | 0.77x | Rs5.52 Billion | Rs4.26 Billion | ▲ +71.0% |
| 2021 | 0.45x | Rs14.63 Billion | Rs6.60 Billion | ▼ -72.5% |
| 2020 | 1.64x | Rs4.49 Billion | Rs7.35 Billion | ▲ +73.8% |
| 2019 | 0.94x | Rs8.12 Billion | Rs7.64 Billion | ▼ -64.2% |
| 2018 | 2.63x | Rs3.12 Billion | Rs8.22 Billion | ▲ +61.5% |
| 2017 | 1.63x | Rs2.89 Billion | Rs4.70 Billion | ▲ +399.1% |
| 2016 | 0.33x | Rs9.30 Billion | Rs3.04 Billion | ▼ -74.9% |
| 2015 | 1.30x | Rs1.72 Billion | Rs2.24 Billion | ▲ +275.2% |
| 2014 | 0.35x | Rs2.36 Billion | Rs819.63 Million | ▲ +6.9% |
| 2013 | 0.32x | Rs2.65 Billion | Rs859.73 Million | ▼ -25.4% |
| 2012 | 0.44x | Rs1.41 Billion | Rs612.56 Million | ▼ -33.1% |
| 2011 | 0.65x | Rs961.81 Million | Rs625.38 Million | — |